Greater China
-
The hammering of Chinese stocks is ominous, but investors should hold out for a turnaround -
Chinese medical device company is seeking about $100m
-
-
In this table, GlobalCapital Asia offers a glimpse of the bond deals that are in the works
-
Asian banks are more likely to redeem their AT1s on the first call date than US peers, despite the costs
-
-
This round-up focuses on the latest GDP numbers as Xi Jinping tightens his grip on China’s ruling party
-
Tencent-backed Chinese healthcare firm remains an IPO hopeful
-
Nickel miner gets a few cornerstones, but deal size is likely to be trimmed
-
This round-up focuses on the potential for further action from the US against China
-
Volumes come under some pressure, but market is ripe for more growth
-
Bharat FIH will list when it is 'commercially beneficial', says Hong Kong-listed Foxconn
